University Hospitals of Toulouse (Rangueil and Salies-Du-Salat)
Toulouse, Midi-Pyrénées, 31059, France
NCT Number: NCT01955031
Severity of diabetes is related to the development of disabling and costly complications (12.9 billion euros in 2007). The French High Health Authority recommends a therapeutic education on lifestyle and dietary rules in first-line treatment of Type 2 Diabetes Mellitus. Despite these recommendations, patients often have difficulties to implement dietary recommendations every day. The objective of EDUC@DOM is to help people with diabetes to improve lifestyle and equilibrium of glycaemia in order to avoid or delay chronic complications of diabetes. Our main goal is to assess effectiveness of our telemonitoring program in type 2 patients' care compared to a usual care of diabetes, on the glycaemia of the patients. It is expected that our program leads to a better monitoring of health status, a greater adherence to medical and non-medical prescriptions, an empowerment of the patient, and as a consequence, a more efficient health care consumption.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toulouse, Midi-Pyrénées, 31059, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A telemonitoring program with educational tools is given to people with type 2 diabetes at their home. It is composed of three softwares to improve eating habits available on touchpad, a self-monitoring blood glucose device, a balance to measure weight and fat mass, and a pedometer to evaluate physical activity. Data are securely sent and stored into a web service which delivers a synthesis to patients and health professionals.
Patients are recruited during therapeutic educational sessions or appointments by general practitioners or diabetologists who take part into the Regional Health Network in Diabetes DIAMIP. If patients accept to participate to the study and sign up the protocol consent, they are given questionnaires about nutrition, physical activity and quality of life. A dietician analyses with each patient the results of a food inquiry. Patients are randomised into two groups: one arm is trained to the telemonitoring program before receiving it at home, and the other arm follows usual care. During 12 months, the telemonitoring group uses the device. The investigators (GP or diabetologists) can use the specific secured website to follow the measured parameters and to make appropriate decisions about health care of their patient. No consultation are scheduled in advance.
Time frame: HbA1c will be measured at Day 0, month 1, month 3, month 6, month 9 and month 12
Time frame: At month 15, month 18, month 21 and month 24
Time frame: At day 0 and month 24
Time frame: At day 0 and month 24
Time frame: At day 0 and month 24
Time frame: At day 0 and month 24
Time frame: At day 0, month 12 and month 24
Time frame: At day 0 and month 24
Time frame: At day 0 and month 24
Time frame: At month 24
Time frame: Everytime patients use the software from Day 0 to month 24
Time frame: Everytime patients use the software from Day0 to month 24
Time frame: Every time patients use the software and the pedometer from day 0 to month 24
Time frame: Everytime patients use the balance from day 0 to month 24
Time frame: Everytime patients use the blood glucose device from day 0 to month 24
Time frame: At month 24
Time frame: At month 24
Time frame: At month 24
University Hospital, Toulouse
Other
Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.
Acronym: EDUC@DOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00729040
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT06268743
Behavior, Diabetes Mellitus
Fredericton, New Brunswick, Canada
View Trial DetailsNCT05524909
Behavior, Diabetes Mellitus
Hong Kong
View Trial DetailsNCT05830318
Asthma, Behavior
Leicester, United Kingdom
View Trial Details